CRNX NASDAQ
Crinetics Pharmaceuticals, Inc.
1W: -3.2%
1M: -5.1%
3M: -14.6%
YTD: -20.6%
1Y: +18.2%
3Y: +67.8%
5Y: +128.7%
$36.80
-0.29 (-0.78%)
Weekly Expected Move ±8.8%
$30
$34
$37
$40
$43
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$18M
Revenue
+2277.5% YoY
$-496M
Net Income
-51.2% YoY
$-420M
Free Cash Flow
-58.1% YoY
98.1%
Gross Margin
-1307.8%
Op. Margin
-1191.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-42.8%
ROA-38.6%
ROIC-3385.4%
Valuation
P/E-7.7
P/B3.0
EV/EBITDA-5.2
Leverage
Debt/Equity0.05
Current Ratio12.32
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z13.52
Beneish M26.13